HT
OLMA icon

Headlands Technologies’s Olema Pharmaceuticals OLMA Stock Holding History

Headlands Technologies’s Portfolio OLMA Stock Details OLMA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$885K Buy
+59,374
New +$1.32M 0.1% 235

Other funds holding OLMA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $4.89B AUM 251.12% 1-Year Est. Return
BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.11B AUM 171.34% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $3.61B AUM 203.3% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return
LGM
Logos Global Management San Francisco, California $2B AUM 444.09% 1-Year Est. Return

Headlands Technologies's OLMA Position: Q1 2026 in Review

Headlands Technologies opened a new position in Olema Pharmaceuticals (OLMA) in Q1 2026: 59,374 shares worth $885K. The stake represents 0.1% of the portfolio and ranks #235 among its holdings.

195 funds tracked by Wall St. Rank hold OLMA as of Q1 2026.

  • Headlands Technologies held 59,374 shares of Olema Pharmaceuticals worth $885K as of Q1 2026.
  • Olema Pharmaceuticals was a new Headlands Technologies position in Q1 2026.
  • Olema Pharmaceuticals made up 0.1% of Headlands Technologies's portfolio in Q1 2026, its #235 holding.
  • 195 funds tracked by Wall St. Rank held Olema Pharmaceuticals as of Q1 2026.

Based on Headlands Technologies's 13F filing for Q1 2026, filed 13 May 2026.